Aastrom Biosciences receives Health Canada approval to begin phase IIb ... pharmabiz.com Dilated cardiomyopathy (DCM), a progressive disease of the heart, is a leading cause of heart failure and heart transplantation. DCM is characterized by weakening of the heart muscle and enlargement of the heart chambers, leading to systolic ... |
